Evidence mapPaperPMID 41102478Full record

SynthesisGeroScience2026

Mortality, functional outcome, and bleeding risk after early versus delayed thrombectomy.

Zoltan Ungvari, János Tibor Fekete, Mónika Fekete, Andrea Lehoczki, Rafal Gulej, Farzaneh Sorond, Eric Liotta, Calin I Prodan, Peter Toth, Csaba Kiss and 2 more

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zoltan Ungvari *Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
János Tibor Fekete *Dept. of Bioinformatics, Semmelweis University, Budapest, 1094, Hungary.
Mónika Fekete *Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Andrea LehoczkiInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Rafal GulejVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Farzaneh SorondDepartment of Neurology, Northwestern University, Feinberg School of Medicine, Chicago, USA.
Eric LiottaDepartment of Neurology, Northwestern University, Feinberg School of Medicine, Chicago, USA.
Calin I ProdanVeterans Affairs Medical Center, Oklahoma City, OK, USA.
Peter TothVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Csaba KissCancer Biomarker Research Group, Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, 1117, Hungary.
Anna UngvariInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary. Ungann2004@gmail.com.ORCID 0009-0001-5053-2828
Balázs GyőrffyDept. of Bioinformatics, Semmelweis University, Budapest, 1094, Hungary.

Funding

CSRD VA I01 CX000340
6 · The paper itself

Abstract

Endovascular thrombectomy (EVT) is an established treatment for acute ischemic stroke, due to large vessel occlusion (LVO), but the optimal time window for intervention remains a subject of ongoing debate. We aimed to assess the impact of treatment timing on mortality, functional outcomes, and safety by comparing early (≤ 6 h) versus late (> 6-24 h) EVT. We conducted a systematic review and meta-analysis to evaluate the effect of time to intervention on outcomes of endovascular thrombectomy (EVT) in acute ischemic stroke. Four databases (PubMed, Web of Science, Cochrane Library, and EMBASE) were searched for studies published between 2000 and 2024. Eligible randomized controlled trials and cohort studies reported on 90-day mortality, functional outcome (modified Rankin Scale, mRS), or symptomatic intracranial hemorrhage (sICH), stratified by treatment timing (≤ 6 h vs. > 6-24 h from symptom onset). Pooled incidence rates, incidence rate differences (IRD), and incidence rate ratios (IRR) were calculated using random-effects models. Eighteen studies met inclusion criteria. The pooled incidence of symptomatic intracranial hemorrhage (sICH) was 0.19 events per person-year (95% CI: 0.12-0.26) in the early group and 0.23 events per person-year (95% CI: 0.11-0.35) in the late group, with no significant difference between groups (incidence rate difference [IRD] - 0.028; p = 0.33, incidence rate ratio [IRR] 0.88; p = 0.33). For mortality, early EVT showed a significantly lower incidence rate of 0.66 events per person-year (95% CI: 0.51-0.82) compared to 0.77 events per person-year (95% CI: 0.63-0.91) in the late EVT group (IRD - 0.148; p = 0.0012, IRR 0.81; p = 0.0014). Functional independence was more frequent in the early group (1.72; 95% CI: 1.42-2.01) than in the late group (1.45; 95% CI: 0.91-1.98) (IRD 0.32; p < 0.0001, IRR 1.22; p < 0.0001). Heterogeneity was moderate to high across outcomes. The timing of endovascular thrombectomy significantly influences clinical outcomes in acute ischemic stroke. Our analysis shows that early intervention (within 6 h) is associated with a significantly lower mortality rate and a higher likelihood of achieving functional independence at 90 days compared to late intervention (beyond 6 up to 24 h). The incidence of symptomatic intracranial hemorrhage did not differ significantly between the groups, suggesting that late treatment does not increase safety risks. These findings underscore the importance of minimizing treatment delays, while also supporting the continued use of EVT in selected patients beyond the 6-h window.

Indexed as

Endovascular ProceduresIntracranial HemorrhagesIschemic StrokeThrombectomyTime-to-TreatmentHumansIncidenceTime FactorsTreatment OutcomeAcute ischemic strokeEndovascular thrombectomyFunctional outcomeLarge vessel occlusionLate interventionMeta-analysisMortalityReperfusion therapyStroke outcomesSymptomatic intracranial hemorrhageTime-to-treatmentTreatment delay

Identifiers

PMID41102478
PMCPMC12972503

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.